What is NMN

Nicotinamide mononucleotide, also known NMN is a Vitamin B3 (niacin) derivative that is a first step precursor to Nicotinamide Adenine Dinucleotide (NAD+). NMN works deep within your body boosting the production of NAD+. It isan extremely powerful and critical molecule found in every cell of the human body. This is vital to a healthy life and longevity.

NMN has recently been focused by many leading scientists because of its potential to be established as leading anti-aging ingredient for pharmaceutical drugs from a nutraceutical. While it occurs naturally in the body, it can be obtained from dietary sources such as fruits, milk, and vegetables as well. By integrating NMN into your healthy, balanced diet, you can increase the level of NAD+ within your cells. It will help boost the body’s longevity gene Sirtuin.

NAD+ is critical to our healthy long life. It is the metabolic fuel for our nervous system but it’s also one of the most important cofactors in immune system health.

If our NAD+ levels dropped to Zero, our bodies would immediately shut down. It is unfortunate but between the ages of 40 and 60, our body begins to lose its innate ability to formulate NAD+ up to 50% of our NAD+ levels. As we age, our cells are unable to produce the level of energy they need to maintain our health. It will be resulted in a significant reduction in quality of life.

NMN has been studied by leading researchers for its benefits and effects on mice. In a study published in a journal Cell, results show that NMN essentially reinvigorate faltering blood flow in aging mice. The mice given NMN added their treadmill run time by 60% in comparison to animals that didn’t receive the molecule. They doubled their exercise endurance — to levels that are equivalent or even surpassed that of younger mice.

You can see NMNhas demonstrated impressive anti-aging effects and benefits on mice. Now the question is if it will work in human body or not. To answerthis question, we can share the first human clinical studyfor NMN conducted in Japan in 2016. The studywas an internationally collaborated between Keio University School ofMedicine in Tokyo and Washington University School of Medicine in St Louis.It was mainly led by Professor Hiroshi Itoh and his team in Keio Universitywith Professor Shinichiro Imai also involved.

In 2018, another study of NMN was published in Cell – quote “Treatment of mice with NAD precursor – nicotinamide mononucleotide improves vascular and increases endurance in ageing mice”. It has given NMN added endorsement on NMN’s anti-aging benefits.